Persistence of humoral response against sporozoite and blood-stage malaria antigens 7 years after a brief exposure to Plasmodium vivax

Journal of Infectious Diseases

Volumn 177, Issue 4, 1998, Pages 1132-1135

  Braga, Érika M ^b   Fontes, Cor J F ^b   Krettli, Antoniana U ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CHLOROQUINE; IMMUNOGLOBULIN G ANTIBODY; MALARIA VACCINE; PARASITE ANTIGEN; PRIMAQUINE; PROTOZOON ANTIBODY; RECOMBINANT PROTEIN;

ADULT; ARTICLE; BLOOD SMEAR; BRAZIL; CHEMOPROPHYLAXIS; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIDEMIC; HUMAN; HUMORAL IMMUNITY; MAJOR CLINICAL STUDY; MALARIA; ORAL DRUG ADMINISTRATION; PARASITE TRANSMISSION; PLASMODIUM VIVAX; PRIORITY JOURNAL; SPOROZOITE;

EID: 0031978051     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/517412     Document Type: Article

References (14)

1. Cruz Marques A. Human migration and the spread of malaria in Brazil. Parasitol Today 1987;3:166-.70.
2. Fontes CJF, Bathurst I, Krettli AU. Plasmodium vivax sporozoite antibodies in individuals exposed during a single malaria outbreak in a non-endemic area. Am J Trop Med Hyg 1991;44:28-33.
3. Nardin EH, Nussenzweig RS, McGregor IA, Bryan JH. Antibodies to sporozoites: their frequent occurrence in individuals living in an area of hyperendemic malaria. Science 1979;206:597-9.
4. McGregor IA. Malarial Immunity: current trends and prospects. Ann Trop Med Parasitol 1987;81:647-56.
5. Druilhe P, Périgon JL. Mechanisms of defense against P. falciparum asexual blood stages in humans. Immunol Lett 1994;41:115-20.
6. Druilhe P, Pradier O, Marc JP, Miltgen F, Mazier D, Parent G. Levels of antibodies to Plasmodium falciparum sporozoite surface antigens reflect malaria transmission rates and are persistent in the absence of reinfection. Infect Immun 1986;53:393-7.
7. Chougnet C, Deloron P, Savel J. Persistence of cellular and humoral response to synthetic peptides from defined Plasmodium falciparum antigens. Ann Trop Med Parasitol 1991;85:357-63.
8. Barr PJ, Gibson HL, Enea V, Arnot DE, Hollingdale MR, Nussenzweig V. Expression in yeast of Plasmodium vivax antigen of potential use in a human malaria vaccine. J Exp Med 1987;165:1160-71.
9. Gibson HL, Tucker JE, Kaslow DC, et al. Structure and expression of the gene for Pv200, a major blood-stage surface antigen of Plasmodium mm. Mol Biochem Parasitol 1992;50:325-34.
10. Carvalho LH, Fontes CJF, Fernandes AAM, Marinuzzi HC, Krettli AU. Cross-reactive cellular immune response to the circumsporozoite proteins of Plasmodium vivax and P. falciparum in malaria-exposed individuals. Parasite Immunol 1997;19:47-59.
11. Brown AE, Webster K, Krinchai K, et al. Characterization of natural antibody responses to the circumsporozoite protein of Plasmodium vivax. Am J Trop Med Hyg 1991;44:21-7.
12. Webster HK, Grincrich JB, Wongsrichanalai C, et al. Circumsporozoite antibody as a serologic marker of Plasmodium falciparum transmission. Am J Trop Med Hyg 1992;47:489-97.
13. Gray D, Skarvall H. B-cell memory is short lived in the absence of antigen. Nature 1988;336:70-3.
14. Bachmann MF, Kündig TM, Hengartner H, Zinkernagel RM. Regulation of IgG antibody titers by the amount persisting of immune-complexed antigen. Eur J Immunol 1994;24:2567-9.